Novartis plans to save about $ 1 billion amid simplification of the structure

Multinational pharmaceutical corporation Novartis plans to integrate its pharmaceutical and oncology divisions into the business of innovative medicines in order to simplify its structure and save at least $ 1 billion by 2024. It is reported by Reuters.

Integration will strengthen competitiveness and lead to synergy, according to the company. As a result, sales growth should increase by at least 4% until 2026, according to her calculations.

Follow the news of the companies in the telegram channel "Catalog of RBC Investments"